Beyond nine years of continuous subthalamic nucleus deep brain stimulation in Parkinson's disease

Movement Disorders

Volumn 26, Issue 13, 2011, Pages 2327-2334

  Zibetti, Maurizio ^a   Merola, Aristide ^a   Rizzi, Laura ^a   Ricchi, Valeria ^a   Angrisano, Serena ^a   Azzaro, Corrado ^a   Artusi, Carlo Alberto ^a   Arduino, Nichy ^a   Marchisio, Alice ^a   Lanotte, Michele ^a   Rizzone, Mario ^a   Lopiano, Leonardo ^a  

^a UNIVERSITY OF TURIN   (Italy)

Author keywords

Deep brain stimulation; Long term follow up; Parkinson's disease; Subthalamic nucleus

Indexed keywords

LEVODOPA;

ADULT; ANEMIA; APRAXIA; ARTICLE; ASTHMA; BRAIN DEPTH STIMULATION; CLINICAL ARTICLE; COGNITION; COGNITIVE DEFECT; COMORBIDITY; CONTROLLED STUDY; DAILY LIFE ACTIVITY; DISABILITY; DISEASE COURSE; DYSARTHRIA; EVALUATION AND FOLLOW UP; FEMALE; HUMAN; HYPERTENSION; HYPERTROPHY; MALE; MOOD; NEUROPSYCHOLOGICAL TEST; NEUROPSYCHOLOGY; OSTEOARTHRITIS; PARKINSON DISEASE; PRIORITY JOURNAL; RADICULOPATHY; RATING SCALE; SEIZURE; SEROMA; SIDE EFFECT; SUBTHALAMIC NUCLEUS; UPPER EXTREMITY DEEP VEIN THROMBOSIS; WEIGHT GAIN;

ACTIVITIES OF DAILY LIVING; AGED; DEEP BRAIN STIMULATION; DISEASE PROGRESSION; DOPAMINE AGENTS; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; PARKINSON DISEASE; PROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; SUBTHALAMIC NUCLEUS; TIME FACTORS; TREATMENT OUTCOME;

EID: 81955168001     PISSN: 08853185     EISSN: 15318257     Source Type: Journal    
DOI: 10.1002/mds.23903     Document Type: Article

References (43)

1. Benabid AL, Chabardes S, Mitrofanis J, Pollak P. Deep brain stimulation of the subthalamic nucleus for the treatment of Parkinson's disease. Lancet Neurol 2009; 1: 67-81.
2. Kleiner-Fisman G, Herzog J, Fisman DN, et al. Subthalamic nucleus deep brain stimulation: summary and meta-analysis of outcomes. Mov Disord 2006; 21( Suppl 14): S290-S304.
3. Deuschl G, Schade-Brittinger C, Krack P, et al. A randomized trial of deep-brain stimulation for Parkinson's disease. N Engl J Med 2006; 355: 896-908.
4. Weaver FM, Follett K, Stern M, et al. Bilateral deep brain stimulation vs best medical therapy for patients with advanced Parkinson disease: a randomized controlled trial. JAMA 2009; 301: 63-73.
5. Williams A, Gill S, Varma T, et al. Deep brain stimulation plus best medical therapy versus best medical therapy alone for advanced Parkinson's disease (PD SURG trial): a randomised, open-label trial. Lancet Neurol 2010; 9: 581-591.
6. Krack P, Batir A, Van Blercom N, et al. Five-year follow-up of bilateral stimulation of the subthalamic nucleus in advanced Parkinson's disease. N Engl J Med 2003; 349: 1925-1934.
7. Schupbach WM, Chastan N, Welter ML, et al. Stimulation of the subthalamic nucleus in Parkinson's disease: a 5 year follow up. J Neurol Neurosurg Psychiatry 2005; 76: 1640-1644.
8. Wider C, Pollo C, Bloch J, Burkhard PR, Vingerhoets FJ. Long-term outcome of 50 consecutive Parkinson's disease patients treated with subthalamic deep brain stimulation. Parkinsonism Relat Disord 2008; 14: 114-119.
9. Romito LM, Contarino MF, Vanacore N, Bentivoglio AR, Scerrati M, Albanese A. Replacement of dopaminergic medication with subthalamic nucleus stimulation in Parkinson's disease: long-term observation. Mov Disord 2009; 24: 557-563.
10. Gervais-Bernard H, Xie-Brustolin J, Mertens P, et al. Bilateral subthalamic nucleus stimulation in advanced Parkinson's disease: five year follow-up. J Neurol 2009; 256: 225-233.
11. Moro E, Lozano AM, Pollak P, et al. Long-term results of a multicenter study on subthalamic and pallidal stimulation in Parkinson's disease. Mov Disord 2010; 25: 578-586.
12. Volkmann, J, Albanese A, Kulisevsky J, et al. Long-term effects of pallidal or subthalamic deep brain stimulation on quality of life in Parkinson's disease. Mov Disord 2009; 24: 1154-1161.
13. Fasano A, Romito LM, Daniele A, et al. Motor and cognitive outcome in patients with Parkinson's disease 8 years after subthalamic implants. Brain 2010; 133: 2664-2676.
14. Emre M. Dementia associated with Parkinson's disease. Lancet Neurol 2003; 4: 229-237.
15. Halpern CH, Rick JH, Danish SF, Grossman M, Baltuch GH. Cognition following bilateral deep brain stimulation surgery of the subthalamic nucleus for Parkinson's disease. Int J Geriatr Psychiatry 2009; 24: 443-451.
16. Witt K, Daniels C, Reiff J, et al. Neuropsychological and psychiatric changes after deep brain stimulation for Parkinson's disease: a randomised, multicentre study. Lancet Neurol 2008; 7: 605-614.
17. Pressley JC, Louis ED, Tang MX, et al. The impact of comorbid disease and injuries on resource use and expenditures in parkinsonism. Neurology 2003; 60: 87-93.
18. Bodenmann P, Ghika J, Van Melle G, Bogousslavsky J. [Neurological comorbidity in parkinsonism]. Rev Neurol (Paris) 2001; 157: 45-54. [French]
19. Hughes AJ, Daniel SE, Kilford L, Lees AJ. Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry 1992; 55: 181-184.
20. Defer GL, Widner H, Marie RM, Remy P, Levivier M. Core assessment program for surgical interventional therapies in Parkinson's disease (CAPSIT-PD). Mov Disord 1999; 14: 572-584.
21. Lanotte MM, Rizzone M, Bergamasco B, Faccani G, Melcarne A, Lopiano L. Deep brain stimulation of the subthalamic nucleus: Anatomical, neurophysiological, and outcome correlations with the effects of stimulation. J Neurol Neurosurg Psychiatry 2002; 72: 53-58.
22. Tomlinson CL, Stowe R, Patel S, Rick C, Gray R, Clarke CE. Systematic review of levodopa dose equivalency reporting in Parkinson's disease. Mov Disord 2010; 25: 2649-2653.
23. Perozzo P, Rizzone M, Bergamasco B, et al. Deep brain stimulation of the subthalamic nucleus in Parkinson's disease: comparison of pre- and postoperative neuropsychological evaluation. J Neurol Sci 2001; 192: 9-15.
24. Raven JC, editor. Coloured Progressive Matrices. London: Lewin; 1962.
25. Spinnler H, Tognoni G. Italian standardisation and normative values of neuropsychological tests. Ital J Neurol Sci 1987; 6( Suppl 8): 1-120.
26. Wechsler D. A standardized memory scale for clinical use. J Psychol 1945; 19: 87-95.
27. Reitan RM. Validity of the Trail Making Test as an indication of organic brain damage. Percept Mot Skills 1958; 8: 271-276.
28. Nelson HE. A modified card sorting test sensitive to frontal lobe defects. Cortex 1976; 12: 313-324.
29. Benton AL. Differential behavioural effects in frontal lobe disease. Neuropsychology 1968; 6: 53-60.
30. Aybek S, Gronchi-Perrin A, Berney A, et al. Long-term cognitive profile and incidence of dementia after STN-DBS in Parkinson's disease. Mov Disord 2007; 22: 974-981.
31. Emre M, Aarsland D, Brown R, et al. Clinical diagnostic criteria for dementia associated with Parkinson's disease. Mov Disord 2007; 22: 1689-1707.
32. Beck AT. Beck Depression Inventory. San Antonio: Psychological Corporation; 1987.
33. Spielberger CD, Gorsuch RL, Lushene RE. S.T.A.I. Questionnaire for state and trait anxiety self-assessment. Firenze: Organizzazioni Speciali; 1980.
34. Limousin P, Krack P, Pollak P, et al. Electrical stimulation of the subthalamic nucleus in advanced Parkinson's disease. N Engl J Med 1998; 339: 1105-1111.
35. Jankovic J, Kapadia AS. Functional decline in parkinson disease. Arch Neurol 2001; 58: 1611-1615.
36. Contarino MF, Daniele A, Sibilia AH, et al. Cognitive outcome 5 years after bilateral chronic stimulation of subthalamic nucleus in patients with Parkinson's disease. J Neurol Neurosurg Psychiatry 2007; 78: 248-252.
37. Visser-Vandewalle V, van der Linden C, Temel Y, et al. Long term effects of bilateral subthalamic nucleus stimulation in advanced parkinson disease: a four year follow-up study. Parkinsonism Relat Disord 2005; 11: 157-165.
38. Rodriguez-Oroz MC, Obeso JA, Lang AE, et al. Bilateral deep brain stimulation in Parkinson's disease: a multicentre study with 4 years follow-up. Brain 2005; 128: 2240-2249.
39. Østergaard K, Aa Sunde N. Evolution of Parkinson's disease during 4 years of bilateral deep brain stimulation of the subthalamic nucleus. Mov Disord 2006; 21: 624-631.
40. Lang AE, Obeso JA. Challenges in Parkinson's disease: restoration of the nigrostriatal dopamine system is not enough. Lancet Neurol 2004; 3: 309-316.
41. van Nuenen BF, Esselink RA, Munneke M, et al. Postoperative gait deterioration after bilateral subthalamic nucleus stimulation in Parkinson's disease. Mov Disord 2008; 23: 2404-2406.
42. Schrag A, Ben-Shlomo Y, Brown R, et al. Young-onset Parkinson's disease revisited-clinical features, natural history, and mortality. Mov Disord 1998; 13: 885-894.
43. Okun MS, Fernandez HH, Wu SS, et al. Cognition and mood in Parkinson's disease in subthalamic nucleus versus globus pallidus interna deep brain stimulation: the COMPARE trial. Ann Neurol 2009; 65: 586-595.